Amedisys Inc (AMED) Stock Rating Reaffirmed by SunTrust Banks, Inc.

Amedisys Inc (NASDAQ:AMED)‘s stock had its “buy” rating restated by SunTrust Banks, Inc. in a research report issued on Friday. They presently have a $70.00 price target on the health services provider’s stock. SunTrust Banks, Inc.’s target price points to a potential upside of 24.44% from the stock’s previous close. SunTrust Banks also issued estimates for Amedisys’ FY2017 earnings at $2.23 EPS, Q1 2018 earnings at $0.59 EPS and Q3 2018 earnings at $0.67 EPS.

AMED has been the topic of several other reports. Mizuho lowered Amedisys from a “buy” rating to a “neutral” rating and set a $50.00 target price on the stock. in a report on Wednesday, July 26th. Benchmark Co. reaffirmed a “hold” rating on shares of Amedisys in a report on Thursday. Robert W. Baird reaffirmed a “hold” rating and set a $50.00 target price on shares of Amedisys in a report on Wednesday, October 4th. Bank of America Corporation began coverage on Amedisys in a report on Monday, August 21st. They set a “neutral” rating and a $55.00 target price on the stock. Finally, BidaskClub raised Amedisys from a “sell” rating to a “hold” rating in a report on Friday, August 11th. Six investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Amedisys presently has an average rating of “Hold” and a consensus price target of $61.00.

Amedisys (NASDAQ:AMED) opened at $56.25 on Friday. Amedisys has a 12 month low of $38.00 and a 12 month high of $65.91. The stock has a market capitalization of $1,913.69, a PE ratio of 26.98, a PEG ratio of 1.37 and a beta of 0.68. The company has a quick ratio of 1.21, a current ratio of 1.33 and a debt-to-equity ratio of 0.16.

Amedisys (NASDAQ:AMED) last announced its quarterly earnings data on Tuesday, November 7th. The health services provider reported $0.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.02. Amedisys had a return on equity of 14.68% and a net margin of 2.88%. The firm had revenue of $380.20 million during the quarter, compared to analysts’ expectations of $384.59 million. During the same period last year, the business posted $0.36 earnings per share. The company’s revenue for the quarter was up 5.1% compared to the same quarter last year. research analysts anticipate that Amedisys will post 2.22 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This article was reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this article on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark laws. The original version of this article can be read at https://www.tickerreport.com/banking-finance/3026658/amedisys-inc-amed-stock-rating-reaffirmed-by-suntrust-banks-inc-2.html.

A number of institutional investors and hedge funds have recently modified their holdings of the business. Wells Fargo & Company MN grew its holdings in Amedisys by 29.7% in the third quarter. Wells Fargo & Company MN now owns 1,484,041 shares of the health services provider’s stock valued at $83,048,000 after purchasing an additional 339,825 shares during the period. Virginia Retirement Systems ET AL acquired a new stake in Amedisys in the third quarter valued at approximately $1,802,000. Legal & General Group Plc grew its holdings in Amedisys by 7.6% in the third quarter. Legal & General Group Plc now owns 59,025 shares of the health services provider’s stock valued at $3,303,000 after purchasing an additional 4,166 shares during the period. FNY Managed Accounts LLC acquired a new stake in Amedisys in the third quarter valued at approximately $900,000. Finally, NorthCoast Asset Management LLC acquired a new stake in Amedisys in the third quarter valued at approximately $262,000. 96.36% of the stock is currently owned by institutional investors.

Amedisys Company Profile

Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.

Analyst Recommendations for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2017 Ticker Report. Google+.